Torii Pharmaceutical Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Torii Pharmaceutical Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Torii Pharmaceutical Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Torii Pharmaceutical Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Torii Pharmaceutical Co Ltd (Torii), a subsidiary of Shionogi & Co LtdJapan Tobacco Inc, specializes in the manufacturing and commercialization of pharmaceutical products targeting chronic kidney disease (CKD), skin diseases, and allergies. The company’s strengths include robust support from its parent company, strategic alliances and collaborationsimprovements in operational performance, a robust distribution network and a diverse product portfolio. However, a limited international footprint increasing operating expenses remain remains a significant area of concern. Torii stands to benefit from leveraging government initiativesm its agreement with ALK-Abello A/S, its promising pipeline products, and the recent regulatory approval of Tapinaroflaunch of new product. Nonetheless, intense competition, rapid technological changes, and stringent regulations may pose challenges to the company's operations.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer